Wrist pain showdown: injection or surgery for de Quervain's?
NCT ID NCT07683429
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study compares two common treatments for De Quervain's tenosynovitis, a painful wrist condition: a single steroid injection versus a minor surgical release. Researchers will track pain levels in 100 adults over six months to see which approach offers better relief. The goal is to help patients and doctors choose the most effective option for this tendon problem.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Triamcinolone acetonide with lidocaine
- What this could lead to
- If one treatment proves clearly better, it could guide doctors and patients toward the most effective option for relieving wrist pain without surgery or with a simple procedure.
- What could go wrong
- This is a small, single-centre study where treatment choice was not random—patients and doctors decided together, which may bias results. The injection or surgery may not work for everyone, and both carry risks like infection or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Apr 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical diagnosis of De Quervain tenosynovitis confirmed by positive Finkelstein test * Age 18-70 years * Pain sufficiently severe to impair activities of daily living * Failure to respond to at least 4 weeks of conservative management Exclusion Criteria: * Concurrent inflammatory arthropathy (rheumatoid arthritis or gout) * History of prior wrist injury * Previous surgical or injection treatment for De Quervain tenosynovitis * Coexisting upper limb pathology (rotator cuff pathology, epicondylitis, or carpal tunnel syndrome)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dequervain's tenosynovitis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rawalpindi Teaching Hospital.
Rawalpindi, Punjab Province, 46000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.